Compass Therapeutics (CMPX) Change in Account Payables: 2023-2025
Historic Change in Account Payables for Compass Therapeutics (CMPX) over the last 3 years, with Sep 2025 value amounting to $500,000.
- Compass Therapeutics' Change in Account Payables rose 315.52% to $500,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.1 million, marking a year-over-year increase of 258.62%. This contributed to the annual value of -$1.8 million for FY2024, which is 360.03% down from last year.
- Latest data reveals that Compass Therapeutics reported Change in Account Payables of $500,000 as of Q3 2025, which was down 50.88% from $1.0 million recorded in Q2 2025.
- Compass Therapeutics' Change in Account Payables' 5-year high stood at $1.8 million during Q4 2023, with a 5-year trough of -$3.2 million in Q1 2024.
- Over the past 3 years, Compass Therapeutics' median Change in Account Payables value was $338,000 (recorded in 2024), while the average stood at -$26,091.
- In the last 5 years, Compass Therapeutics' Change in Account Payables crashed by 114.66% in 2024 and then soared by 315.52% in 2025.
- Quarterly analysis of 3 years shows Compass Therapeutics' Change in Account Payables stood at $1.8 million in 2023, then decreased by 27.75% to $1.3 million in 2024, then spiked by 315.52% to $500,000 in 2025.
- Its last three reported values are $500,000 in Q3 2025, $1.0 million for Q2 2025, and -$672,000 during Q1 2025.